针对全身性红班性狼疮的有效生物标记扮演支持全身性红班性狼疮治疗药开发企业的重要角色，是促进该市场新药研发速度的主要因素。
The identification of valid biomarkers for systemic lupus erythematosus (SLE) will be an important aid to companies developing drugs for SLE and may speed drug development in this market.
针对全身性红班性狼疮的有效生物标记扮演支持全身性红班性狼疮治疗药开发企业的重要角色，是促进该市场新药研发速度的主要因素。
The identification of valid biomarkers for systemic lupus erythematosus (SLE) will be an important aid to companies developing drugs for SLE and may speed drug development in this market.
应用推荐